Orchid Ventures, Inc. Share Price Canadian Securities Exchange
Equities
ORCD
CA68573L2066
Pharmaceuticals
Sales 2020 | 1.45 1.99 120.77 | Sales 2021 | 3.72 5.1 310.37 | Capitalization | 10.45M 14.34M 872M |
---|---|---|---|---|---|
Net income 2020 | -6M -8.23M -501M | Net income 2021 | -3M -4.12M -250M | EV / Sales 2020 | 23,73,049 x |
Net Debt 2020 | 363K 499K 30.32M | Net cash position 2021 | 1M 1.38M 83.68M | EV / Sales 2021 | 25,40,035 x |
P/E ratio 2020 |
-0.45
x | P/E ratio 2021 |
-2.02
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 79.11% |
Managers | Title | Age | Since |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corey Mangold
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |